Io Biotech Inc
(IOBT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,031 | 143,193 | 142,590 | 211,531 | 3,405 |
| TOTAL | $64,951 | $147,255 | $148,219 | $221,738 | $5,635 |
| Non-Current Assets | |||||
| PPE Net | 638 | 847 | 741 | 155 | N/A |
| Other Non-Current Assets | 2,110 | 2,616 | 2,845 | 395 | 18 |
| TOTAL | $2,748 | $3,463 | $3,586 | $550 | $18 |
| Total Assets | $67,699 | $150,718 | $151,805 | $222,288 | $5,653 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,661 | 3,878 | 4,004 | 3,928 | 522 |
| Accrued Expenses | 14,108 | 11,184 | 6,157 | 6,377 | 2,528 |
| TOTAL | $19,486 | $15,717 | $10,676 | $10,305 | $3,050 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,198 | 1,839 | 2,275 | 59 | 37,906 |
| TOTAL | $1,198 | $1,839 | $2,275 | $59 | $37,906 |
| Total Liabilities | $20,684 | $17,556 | $12,951 | $10,364 | $40,956 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,881 | 65,881 | 28,815 | N/A | N/A |
| Common Shares | 66 | 66 | 29 | 29 | 28 |
| Retained earnings | -359,313 | -263,822 | -177,739 | -106,281 | -38,402 |
| Other shareholders' equity | -6,851 | -9,669 | -10,141 | -1,489 | 1,961 |
| TOTAL | $47,015 | $133,162 | $138,854 | $211,924 | $-35,303 |
| Total Liabilities And Equity | $67,699 | $150,718 | $151,805 | $222,288 | $5,653 |